In recent years, Semaglutyd has rapidly gained recognition across Europe and globally for its powerful role in managing type 2 diabetes and assisting with long-term weight loss. Originally developed as a GLP-1 receptor agonist, semaglutide has been proven through multiple clinical trials to support blood sugar regulation, appetite suppression, and significant metabolic improvement. As demand...